Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ODT - ODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics Inc. - ODT


ODT - ODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics Inc. - ODT

ODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODT

PR Newswire

NEW ORLEANS , Dec. 10, 2021 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Odonate Therapeutics, Inc. (NasdaqGS: ODT).

On August 24, 2020 , the Company disclosed disappointing results from the trial of its sole drug candidate, tesetaxel.  On March 22, 2021 , the Company disclosed that it was ending development of tesetaxel following feedback from the U.S. Food and Drug Administration that the drug was unlikely to receive approval on the basis of its clinical data package, and that it would be winding down operations.

The Company has been sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws.  Recently, the court in that case denied the Company's motion to dismiss, allowing the case to move forward

KSF's investigation is focusing on whether Odonate's officers and/or directors breached their fiduciary duties to Odonate's shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Odonate shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ( lewis.kahn@ksfcounsel.com ), or visit https://www.ksfcounsel.com/cases/nasdaqgs-odt/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr. , is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York , California , Louisiana and New Jersey .

To learn more about KSF, you may visit www.ksfcounsel.com .

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn , Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

SOURCE Kahn Swick & Foti, LLC

Stock Information

Company Name: Odonate Therapeutics Inc.
Stock Symbol: ODT
Market: NASDAQ
Website: odonate.com

Menu

ODT ODT Quote ODT Short ODT News ODT Articles ODT Message Board
Get ODT Alerts

News, Short Squeeze, Breakout and More Instantly...